酰胺质子转移成像在新生儿缺氧缺血性脑病中的价值
本文综述酰胺质子转移成像在新生儿缺氧缺血性脑病中的应用价值。该技术通过检测蛋白质含量和pH值变化反映脑组织代谢改变,可在常规MRI未见异常时识别与缺氧缺血性脑病相关的脑区差异,并可能预测远期神经发育结局,但存在局限性,未来需聚焦技术优化、与其他影像技术整合及发现新生物标志物。
要点
- 酰胺质子转移成像可检测蛋白质含量和pH值变化,敏感反映脑内代谢改变。
- 该技术可在常规MRI未见异常时识别与缺氧缺血性脑病相关的脑区差异。
- 研究提示该技术可能预测远期神经发育结局,支持制定个体化康复计划。
核心结论
- 酰胺质子转移成像可提供分子层面信息,有助于新生儿缺氧缺血性脑病的早期诊断和治疗监测,并可能预测远期神经发育结局。
- 该技术与临床实践整合有望显著改善新生儿缺氧缺血性脑病的管理,带来更好的治疗结局和生活质量。
研究设计与样本
- 本文为综述,检索范围与纳入文献原文未报告。
关键影像表现/征象
- 酰胺质子转移成像检测蛋白质含量和pH值变化,反映脑环境中的代谢改变。
- 研究显示该技术可识别与缺氧缺血性脑病相关的脑区差异,即使在常规MRI无异常时也可识别。
诊断标准与关键数值
- 原文未报告敏感度、特异度、AUC、阈值或分级标准的具体数值。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 酰胺质子转移成像存在局限性,原文未逐条列出具体局限内容。
- 未来研究应聚焦技术优化、与其他影像技术整合以及发现新生物标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Neonatal hypoxic-ischemic encephalopathy (HIE) is a critical condition leading to significant neonatal mortality and long-term disability. Timely and accurate diagnosis is vital for effective treatment and improved outcomes. Magnetic resonance imaging (MRI) has emerged as a key tool for assessing brain injury in neonates, with advanced techniques such as amide proton transfer imaging providing insights into tissue metabolism and pH. Amide proton transfer imaging detects changes in protein content and pH values, offering a sensitive reflection of metabolic alterations in the brain environment. Studies have shown that amide proton transfer imaging can identify differences in brain regions associated with HIE, even in the absence of conventional MRI abnormalities. Compared to other imaging modalities, amide proton transfer imaging exhibits high sensitivity in detecting protein content changes and pH, providing molecular-level information that aids in early diagnosis and treatment monitoring. Research also suggests that amide proton transfer imaging can predict long-term neurodevelopmental outcomes, supporting the formulation of personalized rehabilitation plans. Despite its advantages, amide proton transfer imaging has limitations and future research should focus on technical optimization, integration with other imaging techniques, and the discovery of new biomarkers. The integration of amide proton transfer imaging with clinical practice has the potential to significantly improve the management of neonatal HIE, leading to better treatment outcomes and quality of life for affected infants.
引用
- Guo Y, Peng X. Value of amide proton transfer imaging in neonatal hypoxic-ischemic encephalopathy. Pediatr Radiol. 2025. PMID: 40304735. doi:10.1007/s00247-025-06248-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。